معرفی
Prof. Erik de Vries is a Full Professor at the University of Groningen's Faculty of Medical Sciences, affiliated with the Department of Nuclear Medicine and Molecular Imaging at the University Medical Center Groningen (UMCG). He holds dual roles as Research Chair and contact person for contract research within the department. His academic journey includes a PhD from Leiden University (1995) and a career spanning over two decades at the UMCG, where he advanced from Assistant Professor (2008) to Associate Professor (2011) and ultimately Full Professor in Translational Molecular Imaging (2019).
His research focuses on translational molecular imaging, particularly PET imaging applications in neuroinflammation, tumor imaging, and psychiatric/neurodegenerative diseases. Key contributions include developing PET tracers for clinical and preclinical use, leading the Radiochemistry/Radiopharmacy section (2015–2021), and coordinating the MOLAR program (2015–2024) within BCN-BRAIN. He also pioneered the [11C]MeDAS PET tracer for myelin imaging in multiple sclerosis.
Prof. de Vries has extensive international collaboration experience, including roles as Special Visiting Scientist at the University of São Paulo (2014–2016) and ambassador for academic partnerships in Brazil. He has authored/co-authored over 289 publications, edited multi-author textbooks on PET/SPECT imaging in neurology/psychiatry, and contributed to EANM guidelines on leukocyte imaging. His work bridges preclinical research, clinical applications, and industry partnerships.
Grants and collaborations include leadership in the IMPACT-Metastatic Breast Consortium and involvement in projects like the IAEA National Training Course. His research spans drug development (e.g., trimebutine), neurodegenerative diseases (Parkinson’s, Alzheimer’s), and oncological imaging (breast cancer, gliomas). He actively supervises research teams and advises on imaging methodologies through groups like BRIDGE (Basic and Translational Research & Imaging Methodology Development).
